In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease

被引：27
|
作者：
Heinen, Natalie [1 ]
Kloehn, Mara [1 ]
Steinmann, Eike [1 ]
Pfaender, Stephanie [1 ]
机构：
[1] Ruhr Univ Bochum, Dept Mol & Med Virol, D-44801 Bochum, Germany
来源：
VIRUSES-BASEL | 2021年 / 13卷 / 05期
关键词：
SARS-CoV-2; in vitro lung model; cell culture; human airway epithelial cell culture; human lung organoids; lung-on-a-chip; ex vivo lung; air-liquid interface; RESPIRATORY-SYNDROME-CORONAVIRUS; AIRWAY EPITHELIAL-CELLS; EX-VIVO; VIRUS-INFECTION; CILIATED CELLS; SARS; REPLICATION; RECEPTOR; CULTURE; TARGET;
D O I：
10.3390/v13050792
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
SARS-CoV-2 has spread across the globe with an astonishing velocity and lethality that has put scientist and pharmaceutical companies worldwide on the spot to develop novel treatment options and reliable vaccination for billions of people. To combat its associated disease COVID-19 and potentially newly emerging coronaviruses, numerous pre-clinical cell culture techniques have progressively been used, which allow the study of SARS-CoV-2 pathogenesis, basic replication mechanisms, and drug efficiency in the most authentic context. Hence, this review was designed to summarize and discuss currently used in vitro and ex vivo cell culture systems and will illustrate how these systems will help us to face the challenges imposed by the current SARS-CoV-2 pandemic.
引用
收藏
页数：17
相关论文
共 50 条
  • [1] Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation
    Chakraborty, Juhi
    Banerjee, Indranil
    Vaishya, Raju
    Ghosh, Sourabh
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (12) : 6540 - 6555
  • [2] SARS-CoV-2 pathogenesis
    Lamers, Mart M.
    Haagmans, Bart L.
    NATURE REVIEWS MICROBIOLOGY, 2022, 20 (05) : 270 - 284
  • [3] SARS-CoV-2 pathogenesis
    Mart M. Lamers
    Bart L. Haagmans
    Nature Reviews Microbiology, 2022, 20 : 270 - 284
  • [4] Cell and animal models of SARS-CoV-2 pathogenesis and immunity
    Leist, Sarah R.
    Schafer, Alexandra
    Martinez, David R.
    DISEASE MODELS & MECHANISMS, 2020, 13 (09)
  • [5] SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
    Kanimozhi, G.
    Pradhapsingh, B.
    Singh Pawar, Charan
    Khan, Haseeb A.
    Alrokayan, Salman H.
    Prasad, N. Rajendra
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] In Vitro and Animal Models for SARS-CoV-2 research
    Takayama, Kazuo
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (08) : 513 - 517
  • [7] Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
    Udhaya Bharathy Saravanan
    Mayurikaa Namachivayam
    Rajesh Jeewon
    Jian-Dong Huang
    Siva Sundara Kumar Durairajan
    World Journal of Virology, 2022, 11 (01) : 40 - 56
  • [8] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
    K. A. Dvornikova
    E. Yu. Bystrova
    L. P. Churilov
    A. Lerner
    Molecular Biology Reports, 2021, 48 : 5745 - 5758
  • [9] The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease
    Chana-Cuevas, Pedro
    Salles-Gandara, Philippe
    Rojas-Fernandez, Alejandro
    Salinas-Rebolledo, Constanza
    Milan-Sole, Anna
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [10] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
    Dvornikova, K. A.
    Bystrova, E. Yu.
    Churilov, L. P.
    Lerner, A.
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5745 - 5758
12345